General Archive
-
News releasesDementia care digital platform launched by partnership including MRC Technology
Brain health company IXICO launched a digital platform, Project Cygnus, to support patients with the diseases that cause dementia. IXICO…
-
News releases
MRC Technology collaborates with NYU School of Medicine to develop biologics for inflammatory bone disease
MRC Technology and NYU School of Medicine have signed an agreement to develop an antibody for the prevention of inflammatory…
-
News releases
MRC Technology appoints Finance Director
MRC Technology has appointed Andrew Mercieca as its Finance Director from 1 April 2015. Andrew joined the company as Interim…
-
News releases
MRC Technology Negotiates Licence Deal with Quantifoil Micro Tools GmbH for Ultrastable Gold Support (UltrAuFoil) Technology
MRC Technology announced it has negotiated a licence for ultrastable gold supports developed at the MRCLaboratory of Molecular Biology, with…
-
Articles
Immunotherapy drugs could herald new era in cancer treatment
Immunotherapy, which uses the body’s own defence mechanism, is at long last becoming accepted as a frontline treatment for cancer,…
-
News releases
MRC Technology and Cyclofluidic announce the successful completion of a hit optimisation project
MRC Technology (MRCT) and Cyclofluidic Ltd have announced the successful completion of their collaboration to identify and optimise drug-like molecules…
-
News releases
First Treatment Approved under EAMS Developed Using MRC Technology Antibody Humanization Expertise
Pembrolizumab, humanized by MRC Technology, is the the first drug to be approved through the Early Access to Medicine Scheme…
-
Articles
Immunotherapy: boosting your body to fight cancer
The basic idea behind immunotherapy for cancer is to stimulate the body’s immune system to attack a cancer rather than…
-
News releases
Respiratory ‘Call for Targets’ launched
‘Call for targets’ launched to find new therapeutic concepts for treatment of respiratory disease, including conditions such as allergy, acute…
-
News releases
MRC Technology appoints General Counsel and Company Secretary
Dr Edward Bliss appointed in new role of General Counsel and Company Secretary.
-
Articles
Kick-starting stalled drugs for brain diseases
MRC Technology and charity partners launched a consortium to uncover promising drugs in pharma libraries that could be developed to…
-
News releases
MRC Technology to manage Diabetes UK’s IP
MRC Technology has signed an agreement with Diabetes UK to manage its intellectual property (IP). The partnership will enable Diabetes…